NO20020916L - GAS1-polypeptider - Google Patents

GAS1-polypeptider

Info

Publication number
NO20020916L
NO20020916L NO20020916A NO20020916A NO20020916L NO 20020916 L NO20020916 L NO 20020916L NO 20020916 A NO20020916 A NO 20020916A NO 20020916 A NO20020916 A NO 20020916A NO 20020916 L NO20020916 L NO 20020916L
Authority
NO
Norway
Prior art keywords
protein
gas1
lethal
cell
sequence encoding
Prior art date
Application number
NO20020916A
Other languages
English (en)
Other versions
NO20020916D0 (no
Inventor
Walter Herman Maria Lou Luyten
Jose Ramon Naranjo
Britt Mellstrom
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20020916D0 publication Critical patent/NO20020916D0/no
Publication of NO20020916L publication Critical patent/NO20020916L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Psychology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Plant Pathology (AREA)
NO20020916A 1999-08-24 2002-02-25 GAS1-polypeptider NO20020916L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99306702 1999-08-24
PCT/EP2000/008182 WO2001014549A1 (en) 1999-08-24 2000-08-21 Gas1 polypeptides

Publications (2)

Publication Number Publication Date
NO20020916D0 NO20020916D0 (no) 2002-02-25
NO20020916L true NO20020916L (no) 2002-04-24

Family

ID=8241594

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020916A NO20020916L (no) 1999-08-24 2002-02-25 GAS1-polypeptider

Country Status (14)

Country Link
US (1) US20080085861A1 (no)
EP (1) EP1212421B1 (no)
JP (1) JP2003507067A (no)
KR (1) KR20020019572A (no)
AT (1) ATE309355T1 (no)
AU (1) AU783872B2 (no)
CA (1) CA2382674A1 (no)
DE (1) DE60023921T2 (no)
ES (1) ES2253251T3 (no)
IL (1) IL148311A0 (no)
NO (1) NO20020916L (no)
NZ (1) NZ516870A (no)
WO (1) WO2001014549A1 (no)
ZA (1) ZA200201478B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX361195B (es) * 2014-05-23 2018-11-13 Centro De Investig Y De Estudios Avanzados Del I P N Sistema de nanoparticulas genicas con efecto apoptotico y especificidad tumoral para el tratamiento de cancer.

Also Published As

Publication number Publication date
ES2253251T3 (es) 2006-06-01
ZA200201478B (en) 2004-04-28
EP1212421B1 (en) 2005-11-09
DE60023921D1 (en) 2005-12-15
ATE309355T1 (de) 2005-11-15
CA2382674A1 (en) 2001-03-01
DE60023921T2 (de) 2006-08-10
IL148311A0 (en) 2002-09-12
JP2003507067A (ja) 2003-02-25
NZ516870A (en) 2003-10-31
NO20020916D0 (no) 2002-02-25
US20080085861A1 (en) 2008-04-10
AU7411700A (en) 2001-03-19
AU783872B2 (en) 2005-12-15
WO2001014549A1 (en) 2001-03-01
EP1212421A1 (en) 2002-06-12
KR20020019572A (ko) 2002-03-12

Similar Documents

Publication Publication Date Title
BRPI0412401A (pt) polipeptìdeos da amilase exoespecìficos, ácidos nucléicos que codificam tais polipeptìdeos e usos dos mesmos
NO20031129D0 (no) Varianter av human koagulasjonsfaktor VII
WO2003104270A3 (en) GENES OF DUDULINE 2, EXPRESSION PRODUCTS, NON-HUMAN ANIMAL MODEL: USES IN HUMAN HEMATOLOGICAL DISEASES
ATE299185T1 (de) Hemmung der expression von genen mittels dsrna
MXPA02005337A (es) Control biologico por sistema generico letal, dominante, condicional.
DE60330923D1 (de) Menschliche Koagulationsfaktor VII Polypeptide
DE69828512D1 (de) Granulierter plasmaproteinfutterzusatz mit erhöhter biowirksamkeit
EA200600868A1 (ru) Гидрогенолиз сахарного сырья
CY1108459T1 (el) Ακτ-3 νουκλεϊκα οξεα, πολυπεπτιδια, και χρησεις αυτων
AR017887A1 (es) Estructuras artificiales de acidos nucleicos, procedimiento para su preparacion, celula aislada y uso de dichas estructuras y dicha celula para lamanufactura de un medicamento
DK1290160T3 (da) Humane Pellino-polypeptider
DE60016363D1 (de) Aminoalkohol-Derivat und Medikament, das dieses Derivat enthält
NO20013102L (no) Gener, proteiner og deres anvendelse
ATE309355T1 (de) Gas1-polypeptide
ATE327253T1 (de) Proteine und nukleinsäuremoleküle des kopfes, des nervenkords, der tieferen darmabschnitte und des malpighi-gefässes des flohs und ihre verwendungen
DK1075523T3 (da) Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf
ATE309270T1 (de) ßSMOOTHENEDß PROTEINE AUS WIRBELTIEREN
ATE322906T1 (de) Verwendung von langem pentraxin ptx3 zur behanlung von durch geänderte aktivität des fgf-2 wachstumsfaktors hervorgerufene krankheiten
DK1339853T3 (da) Isolerede luciferaser og deres anvendelse
NO995692D0 (no) Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse
NO952601L (no) Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser
NO20016089D0 (no) Nuklein- og proteinsyrer som svarer til det humane gen ABC1
NO20014011L (no) Glukosedehydrogenasefusjonsproteiner og deres anvendelse i ekspresjonssystemer
DE60129228D1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
FI981217A0 (fi) GFRalfa2 negatiiviset hiiret toimivat kokeellisina malleina eräille ihmisen taudeille

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application